Home › Funds › Frazier Life Sciences Management, L.P. › NAMSW
Frazier Life Sciences Management, L.P. position in NAMSW
NEWAMSTERDAM PHARMA COMPANY · Materials
Frazier Life Sciences Management, L.P. reported holding 500,333 shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 0.23% of its reported portfolio and ranking #38 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed NAMSW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s NAMSW position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in NAMSW in Q3 2023 at 500,333 shares (US$951K). The position peaked in Q4 2025 at 500,333 shares, worth US$11.5M. Across 12 filings, Frazier Life Sciences Management, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 500,333 shares valued at US$10.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 500.33K | $950.63K | New |
| Q4 2023 | 500.33K | $1.57M | Hold |
| Q1 2024 | 500.33K | $5.52M | Hold |
| Q2 2024 | 500.33K | $4.36M | Hold |
| Q3 2024 | 500.33K | $3.50M | Hold |
| Q4 2024 | 500.33K | $7.13M | Hold |
| Q1 2025 | 500.33K | $4.50M | Hold |
| Q2 2025 | 500.33K | $4.00M | Hold |
| Q3 2025 | 500.33K | $8.56M | Hold |
| Q4 2025 | 500.33K | $11.51M | Hold |
| Q1 2026 | 500.33K | $10.03M | Hold |
| Q2 2026 | 500.33K | $10.69M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NAMSW and 13F data
NAMSW (NEWAMSTERDAM PHARMA COMPANY) is a Materials company. 10 other funds we track also report a position in NAMSW — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$2.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NAMSW
- Bain Capital Life Sciences Investors, LLC 100.00K sh · $2.14M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held NAMSW?
Frazier Life Sciences Management, L.P. has disclosed NAMSW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Frazier Life Sciences Management, L.P.'s current position in NAMSW?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 500.33K shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY), valued at $10.69M, representing 0.23% of its reported portfolio and ranking #38.
Has Frazier Life Sciences Management, L.P. been buying or selling NAMSW?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in NAMSW. The position peaked in Q4 2025 at 500.33K shares.
Which other funds hold NAMSW?
Other major institutional holders of NAMSW include Bain Capital Life Sciences Investors, LLC, among 10 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.